lymphocytes but that they express certain monocyte related markers and class II MHC antigens.5 Functionally, Facb-R+ cells are non-phagocytic4 and lack cytotoxic activity but act as regulatory cells in pokeweed mitogen driven IgG synthesis. 6 The factors which promote the increase in Facb-R+ cells in rheumatoid peripheral blood are unknown. Experiments in mice have shown that splenic Facb-R+ cells increase in number after secondary but not primary immunisation with a specific antigen, sheep erythrocytes. 7 
Results

IN VIVO RESPONSES TO SOLUBLE ANTIGENS
Six subjects were immunised intramuscularly with tetanus toxoid at a dose of 40 international units. Peripheral blood samples were taken at intervals over 14 days and levels of Facb-R+ cells determined. These were expressed relative to day 0 values and are presented in Fig. 1 (upper half). There was a significant increase in numbers of circulating Facb-R+ cells from 2*9 (0-5) x 104/ml (mean (SD)) on day 0 to 5.9 (2-4)xl14/ml on day 3 (p<005), returning to preimmunisation values by day 7. Of 17 healthy individuals challenged intradermally with another specific antigen, tuberculin, 12 showed a positive reaction after 48 hours and (Fig. 2) . When Percoll fractionated cells were examined from subjects who responded positively to the Tine test enhanced binding of MAb 7*2 was visible in the low density fraction postimmunisation ( Table 2) .
The rise in Facb-R+ cell numbers after immunisation with specific antigens was compared with levels of these cells in groups of patients with active rheumatoid arthritis and Felty's syndrome. The results shown in Fig. 3 demonstrate that patients with Felty's syndrome had considerably higher levels of circulating Facb-R+ cells (12*1(3-0)xlO4/ ml) than the active rheumatoid group (9-3(5.2) x 104/ ml, p<O-01). Both groups had a higher proportion of Facb-R+ cells in their PBMNC than normal (Table 3 ). The enhance- 
